<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01400360</url>
  </required_header>
  <id_info>
    <org_study_id>JohannWGUH_IMCVS</org_study_id>
    <nct_id>NCT01400360</nct_id>
  </id_info>
  <brief_title>Invasive Diagnostic and Therapeutic Management of Cerebral Vasospasm After Aneurysmatic Subarachnoid Hemorrhage</brief_title>
  <acronym>IMCVS</acronym>
  <official_title>Invasive Diagnostic and Therapeutic Management of Cerebral Vasospasm After Aneurysmatic Subarachnoid Hemorrhage</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johann Wolfgang Goethe University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Johann Wolfgang Goethe University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cerebral vasospasm(CVS) after subarachnoid hemorrhage (SAH) results in a considerable amount
      of transient or even permanent neurological deficits and poor outcome of the patients.
      Transluminal Balloon angioplasty (TBA) or intraarterial application of vasodilators
      represents a rescue therapy for severe CVS. Indication, duration and efficacy of this
      treatment, however, is still under debate. Aim of the study is to investigate if such a
      rescue treatment can significantly reduce new delayed ischemic cerebral deficits after SAH.
      Hypothesis is that the occurance of delayed infarcts can be reduced by repetetive
      intraarterial therapy to more than 50 %.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>August 2009</start_date>
  <primary_completion_date type="Anticipated">August 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>New infarcts between baseline and final MRI</measure>
    <time_frame>21 + - 7 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinical outcome (mRS, Karnofsky)</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">92</enrollment>
  <condition>Cerebral Vasospasm After Subarachnoid Hemorrhage</condition>
  <arm_group>
    <arm_group_label>invasive</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>After proof of perfusion relevant CVS in interventional therapy should be performed as best possible combination from TBA and intraarterial vasodilators additional to the conventional treatment.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>conventional</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>After proof of perfusion relevant CVS only conventional treatment should be performed (no intraarterial therapy).</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Combination of TBA and intraarterial application of vasodilators</intervention_name>
    <description>In the invasive arm CVS should be treated by intraarterial therapy and efficacy controlled by CT or MRI after 48 hours and if necessary repeated.</description>
    <arm_group_label>invasive</arm_group_label>
    <arm_group_label>conventional</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  SAH (WFNS 1-4)

          -  Perfusion relevant CVS

          -  Ability for MRI, DSA and intraarterial treatment

        Exclusion Criteria:

          -  extended cerebral infarcts

          -  SAH or ICH from AVM or flow associated aneurysm

          -  Non aneurismal SAH

          -  Relevant non spastic stenosis of brain supplying arteries
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Hartmut Vatter, M. D.</last_name>
    <phone>069 / 6301</phone>
    <phone_ext>5939</phone_ext>
    <email>h.vatter@em.uni-frankfurt.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Joachim Berkefeld, M. D.</last_name>
    <phone>069/ 6301</phone>
    <phone_ext>5462</phone_ext>
    <email>j.berkefeld@em.uni-frankfurt.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Neurochirurgische Klinik, Universitätsklinik</name>
      <address>
        <city>Düsseldorf</city>
        <zip>40225</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Department of Neurosurgery, Johann Wolfgang Goethe-University</name>
      <address>
        <city>Frankfurt am Main</city>
        <zip>60528</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hartmut Vatter, M. D.</last_name>
      <phone>069/ 6301</phone>
      <phone_ext>5939</phone_ext>
      <email>h.vatter@em.uni-frankfurt.de</email>
    </contact>
    <contact_backup>
      <last_name>Joachim Berkefeld, M. D.</last_name>
      <phone>069/ 6301</phone>
      <phone_ext>5462</phone_ext>
      <email>j.berkefeld@em.uni-frankfurt.de</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Neurochirurgische Klinik der Universität Ulm</name>
      <address>
        <city>Günzburg</city>
        <zip>89312</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ralph König, M. D.</last_name>
      <phone>08221</phone>
      <phone_ext>9600</phone_ext>
      <email>ralph.koenig@uni-ulm.de</email>
    </contact>
    <investigator>
      <last_name>Ralph König, M. D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Klinik für Neurochirurgie, Universitätsklinikum</name>
      <address>
        <city>Jena</city>
        <zip>07743</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rolf Kalff, M. D.</last_name>
      <phone>093641</phone>
      <phone_ext>9323001</phone_ext>
      <email>rolf.kalff@med.uni-jena.de</email>
    </contact>
    <contact_backup>
      <last_name>Steffi Neumann</last_name>
      <phone>03641</phone>
      <phone_ext>9324765</phone_ext>
      <email>steffi.neumann@med.uni-jena.de</email>
    </contact_backup>
    <investigator>
      <last_name>Rolf Kalff, M. D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Klinik für Neurochirurgie, Universitätsklinikum</name>
      <address>
        <city>Mannheim</city>
        <zip>68169</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <link>
    <url>http://www.kgu.de/neurochirurgie</url>
    <description>Department of Neurosurgery, Johann Wolfgang Goethe University, Frankfurt am Main</description>
  </link>
  <verification_date>May 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 21, 2011</study_first_submitted>
  <study_first_submitted_qc>July 21, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 22, 2011</study_first_posted>
  <last_update_submitted>July 21, 2011</last_update_submitted>
  <last_update_submitted_qc>July 21, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 22, 2011</last_update_posted>
  <responsible_party>
    <name_title>Hartmut Vatter, M.D.</name_title>
    <organization>Dept. of Neurosurgery, Goethe-University Frankfurt</organization>
  </responsible_party>
  <keyword>cerebral vasospasm</keyword>
  <keyword>subarachnoid hemorrhage</keyword>
  <keyword>transluminal balloon angioplasty</keyword>
  <keyword>intraarterial treatment</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemorrhage</mesh_term>
    <mesh_term>Subarachnoid Hemorrhage</mesh_term>
    <mesh_term>Vasospasm, Intracranial</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vasodilator Agents</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

